COMPUGEN LTD (CGEN) Forecast, Price Target & Analyst Ratings

NASDAQ:CGEN • IL0010852080

Current stock price

2.58 USD
+0.1 (+4.03%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for COMPUGEN LTD (CGEN).

Forecast Snapshot

Consensus Price Target

Price Target
$6.38
+ 147.09% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 18, 2026
Period
Q1 / 2026
EPS Estimate
-$0.07
Revenue Estimate
2.492M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
87.27%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$6.38
Upside
+ 147.09%
From current price of $2.58 to mean target of $6.38, Based on 11 analyst forecasts
Low
$4.04
Median
$4.08
High
$13.65

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

11 Wall Street analysts provided a forecast for the next 12 months for CGEN. The average price target is 6.38 USD. This implies a price increase of 147.09% is expected in the next year compared to the current price of 2.58.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CGEN Current Analyst RatingCGEN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

CGEN Historical Analyst RatingsCGEN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
87.27%
CGEN was analyzed by 11 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about CGEN.
In the previous month the buy percentage consensus was at a similar level.
CGEN was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-07Lake StreetInitiate Buy
2026-01-07HC Wainwright & Co.Initiate Buy
2024-05-21Truist SecuritiesMaintains Buy -> Buy
2024-03-08Truist SecuritiesMaintains Buy -> Buy
2023-12-19StifelMaintains Buy -> Buy
2023-08-23Truist SecuritiesReiterate Buy -> Buy
2023-08-07EF HuttonReiterate Buy -> Buy
2023-06-06EF HuttonReiterate Buy
2023-05-26EF HuttonReiterate Buy -> Buy
2023-05-24EF HuttonReiterate Buy -> Buy
2023-05-16OppenheimerMaintains Outperform -> Outperform
2023-02-28OppenheimerReiterate Outperform
2023-02-08JefferiesDowngrade Hold -> Underperform
2023-01-05EF HuttonInitiate Buy
2022-11-15OppenheimerMaintains Outperform
2022-08-23Truist SecuritiesMaintains Buy
2022-08-08JMP SecuritiesMaintains Market Outperform
2022-08-08OppenheimerMaintains Outperform
2022-08-05JefferiesDowngrade Buy -> Hold
2022-02-25OppenheimerMaintains Outperform
2022-02-25SVB LeerinkMaintains Outperform
2021-04-06SVB LeerinkMaintains Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 18, 2026
Period
Q1 / 2026
EPS Estimate
-$0.07
Revenue Estimate
2.492M
Revenue Q2Q
9.11%
EPS Q2Q
6.50%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
95.45%
Revenue (3 Months)
95.45%
EPS (1 Month)
8.34%
EPS (3 Months)
2.23%

Next Earnings Summary

CGEN is expected to report earnings on 5/18/2026. The consensus EPS estimate for the next earnings is -0.07 USD and the consensus revenue estimate is 2.49M USD.
The next earnings revenue estimate has been revised upward by 95.45% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CGEN revenue by date.CGEN revenue by date.
33.459M
346.12%		27.864M
-16.72%		72.764M
161.14%		19.803M
-72.78%		42.056M
112.37%		41.435M
-1.48%		31.266M
-24.54%		52.852M
69.04%		98.961M
87.24%		82.853M
-16.28%		99.141M
19.66%
EBITDA
YoY % growth
CGEN ebitda by date.CGEN ebitda by date.
-12.516M
64.13%		-14.405M
-15.09%		31.801M
320.76%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CGEN ebit by date.CGEN ebit by date.
-12.992M
63.27%		-14.891M
-14.62%		31.326M
310.37%		-25.313M
-180.80%		-22.714M
10.27%		-26.525M
-16.78%		-38.72M
-45.98%		-11.188M
71.11%		18.029M
261.15%		32.748M
81.64%		77.609M
136.99%
Operating Margin
CGEN operating margin by date.CGEN operating margin by date.
-38.83%-53.44%43.05%-127.82%-54.01%-64.02%-123.84%-21.17%18.22%39.53%78.28%
EPS
YoY % growth
CGEN eps by date.CGEN eps by date.
-0.22
45.00%		-0.16
27.27%		0.37
331.25%		-0.22
-158.99%		-0.17
23.36%		-0.40
-137.80%		-0.37
5.97%		-0.03
91.82%		0.03
200.00%		0.39
1,166.67%		0.71
84.21%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.07
6.50%		-0.07
10.75%		-0.07
-6.85%		-0.04
-107.37%
Revenue
Q2Q % growth		2.492M
9.11%		2.492M
98.25%		2.492M
31.78%		6.929M
-89.71%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-7.568M
9.85%		-7.325M
13.10%		-7.546M
4.40%		-3.463M
-106.18%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CGEN Yearly Revenue VS EstimatesCGEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 20M 40M 60M 80M
CGEN Yearly EPS VS EstimatesCGEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 0.5 -0.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-45.42%
EPS Next 5 Year
-15.80%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
81.75%
Revenue Next 5 Year
50.25%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

COMPUGEN LTD / CGEN Forecast FAQ

What is the price target for CGEN stock?

11 analysts have analysed CGEN and the average price target is 6.38 USD. This implies a price increase of 147.09% is expected in the next year compared to the current price of 2.58.

Can you provide the upcoming earnings date for COMPUGEN LTD?

COMPUGEN LTD (CGEN) will report earnings on 2026-05-18.

What are the consensus estimates for COMPUGEN LTD (CGEN) next earnings?

The consensus EPS estimate for the next earnings of COMPUGEN LTD (CGEN) is -0.07 USD and the consensus revenue estimate is 2.49M USD.

Can you provide the consensus rating for COMPUGEN LTD stock?

The consensus rating for COMPUGEN LTD (CGEN) is 87.2727 / 100 . This indicates that analysts generally have a positive outlook on the stock.